To demonstrate that the observed cell proliferation inhibition of three pancreatic cancer cells is due to CREPT degradation rather than the disruption of the CREPT homodimers caused by the non-degrading peptide, we synthesized a PRTC mutant lacking the VHL recruiting domain, named PRTC-v. The gene discussed is VHL; the disease is pancreatic neoplasm.